Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,203,783
-$220,294 QoQ
Shares Held
49,991
-1.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,214
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bryn Mawr Trust Advisors, LLC holds $73,679,493 across 10 Drug Manufacturers - General names. PFE ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
220,148 | $28,289,018 | |
| 2 | JNJ |
Johnson & Johnson
|
107,673 | $27,345,711 | |
| 3 | AZN |
Astrazeneca PLC
|
27,799 | $5,271,246 | |
| 4 | LLY |
ELI LILLY & Co
|
3,407 | $4,086,458 | |
| 5 | AMGN |
Amgen Inc
|
9,560 | $3,461,867 | |
| 6 | ABBV |
AbbVie Inc.
|
8,879 | $2,234,311 | |
| 7 | PFE |
Pfizer Inc
This page
|
49,991 | $1,203,783 | |
| 8 | NVS |
Novartis AG
|
5,909 | $926,058 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,203,783 | 49,991 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,424,077 | 50,715 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,976,238 | 79,367 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,958,571 | 76,867 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,865,510 | 76,960 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,745,545 | 68,885 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,913,688 | 72,133 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,443,983 | 84,450 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $5,429,099 | 194,035 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $5,556,687 | 200,241 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $5,021,436 | 174,416 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $8,079,847 | 243,589 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,074,441 | 220,132 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $8,487,134 | 208,018 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $11,058,668 | 215,821 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $532,340 | 12,165 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $641,481 | 12,235 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $654,113 | 12,635 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $713,619 | 12,085 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $525,367 | 12,215 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $396,886 | 10,135 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $367,191 | 10,135 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $371,265 | 10,086 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $392,175 | 10,686 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $285,111 | 8,719 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $404,213 | 12,384 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||